Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-04-13 16:35:46 ET · period of report 2026-04-09 · accession 0001464583-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-13 16:35 | 2026-04-09 | KNSA | Megna Michael R | CAO | S - Sale | $46.69 | -6,625 | 27.4K | -19% | -$309.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-04-09 | S | D | 6,625 | $46.69 | 27,418 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025. |